1. Home
  2. WST vs J Comparison

WST vs J Comparison

Compare WST & J Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • J
  • Stock Information
  • Founded
  • WST 1923
  • J 1947
  • Country
  • WST United States
  • J United States
  • Employees
  • WST N/A
  • J N/A
  • Industry
  • WST Medical/Dental Instruments
  • J Military/Government/Technical
  • Sector
  • WST Health Care
  • J Industrials
  • Exchange
  • WST Nasdaq
  • J Nasdaq
  • Market Cap
  • WST 18.0B
  • J 17.5B
  • IPO Year
  • WST N/A
  • J N/A
  • Fundamental
  • Price
  • WST $272.51
  • J $154.58
  • Analyst Decision
  • WST Strong Buy
  • J Buy
  • Analyst Count
  • WST 8
  • J 9
  • Target Price
  • WST $333.71
  • J $155.25
  • AVG Volume (30 Days)
  • WST 675.2K
  • J 722.3K
  • Earning Date
  • WST 10-23-2025
  • J 11-18-2025
  • Dividend Yield
  • WST 0.32%
  • J 0.83%
  • EPS Growth
  • WST N/A
  • J N/A
  • EPS
  • WST 6.68
  • J 4.00
  • Revenue
  • WST $2,960,200,000.00
  • J $11,835,289,000.00
  • Revenue This Year
  • WST $6.28
  • J N/A
  • Revenue Next Year
  • WST $6.02
  • J $6.63
  • P/E Ratio
  • WST $40.77
  • J $39.25
  • Revenue Growth
  • WST 2.90
  • J 61.50
  • 52 Week Low
  • WST $187.43
  • J $105.18
  • 52 Week High
  • WST $352.33
  • J $155.90
  • Technical
  • Relative Strength Index (RSI)
  • WST 66.82
  • J 67.96
  • Support Level
  • WST $249.76
  • J $147.52
  • Resistance Level
  • WST $262.90
  • J $152.07
  • Average True Range (ATR)
  • WST 6.38
  • J 2.82
  • MACD
  • WST 1.40
  • J 0.61
  • Stochastic Oscillator
  • WST 83.27
  • J 88.31

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About J Jacobs Solutions Inc.

Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $11.5 billion in revenue in fiscal 2024.

Share on Social Networks: